Back

Left atrial reservoir strain is an independent prognostic predictor in patients undergoing percutaneous mitral valve repair

28 August 2022 (10:15 - 11:00)
Organised by:
Congress Presentation Part of: Transcatheter interventions for structural heart disease Systolic and Diastolic Function ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Elena Galli

University Hospital of Strasbourg, Strasbourg (France)

6 More presentations in this session

Presentation thumbnail
Can a simple echocardiographic Doppler VTI based flow comparison between the RVOT and LVOT assist in identifying patients with a significant atrial septal defect?
Doctor N. Khav (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Peak atrial longitudinal strain as an independent predictor of composite endpoint in patients received aortic valve replacement for severe aortic stenosis: a prospective cohort study
Miss Q. Ren (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Right ventricular free wall longitudinal strain (RVFWSL) a new outcome predictor in patients candiate for TAVI.
Doctor C. Dellino (Padova, IT)
Abstract Slides
Presentation thumbnail
Intracardiac echocardiography as transesophageal echocardiography replacement in percutaneous intervention imaging: a systematic review and meta-analysis
Ms A. Pritazahra (London, GB)
Abstract Slides
Presentation thumbnail
Acute impact of transcatheter edge-to-edge repair for mitral regurgitation on left ventricular function
Doctor M. Kassar (Bad Oeynhausen, DE)
Abstract Slides

Access the full session

Session thumbnail
Transcatheter interventions for structural heart disease

The Event

Event poster

ESC Congress 2022

28 August 2022 10:15 CET
You may be interested in
thumbnail
Congress Session
Recent advances in clinical practice guidelines: what the imager needs to know and apply - Part 2
thumbnail
Congress Presentation
Diastolic function and left atrial pressures
thumbnail
Congress Presentation
Threshold values for diastolic dysfunction parameters indicative of increased mortality risk in a real-world patient cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources